The second infection was also tied to a 50% or greater increase in several specific long-COVID conditions, including ...

Small-molecule inhibitors targeting viral proteins could serve as an effective alternative for controlling the spread of COVID-19 at both individual and community levels. In this vein, a recent study ...

A large-scale French study finds that patients hospitalized with COVID-19 face a significantly higher risk of long-term organ disorders, hospitalization, and mortality for up to 30 months post ...

New antibodies show potential to defeat all SARS-CoV-2 variants Date: March 5, 2025 Source: Stanford University Summary: A team has found two antibodies that can work together to neutralize the ...

SARS (severe acute respiratory syndrome) and MERS (Middle East respiratory syndrome) are serious infectious respiratory diseases that are caused by members of a class of viruses known as coronaviruses ...

In SARS-CoV-2 infection, there is an association between infection severity and T-cell and NK cell dysfunction and lymphopenia; therefore, selenium deficiency needs to be considered in severe ...

The COVID-19 pandemic highlighted the urgent need for effective therapeutic agents against SARS-CoV-2. Although vaccines ...

The health benefits of Ashwagandha are vast. It is used as adaptogen to reduce stress and anxiety by lowering cortisol levels ...

For all the mysteries that remain about the novel coronavirus and the COVID-19 disease it causes, scientists have generated an incredible amount of fine-grained knowledge in a surprisingly short time.